SCHEMBL19397604

SCHEMBL19397604

c1ccc(-c2ccc(-c3cc(-c4cc(-c5ccc6ccccc6c5)cc(-c5ccc6ccccc6c5)c4)nc(-c4cccc5c4oc4ccccc45)n3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
CYP1A1 P04798 1/20 0.42
CYP1B1 Q16678 1/20 0.42
ALDH1A1 P00352 3/20 0.38
MAPT P10636 3/20 0.38
PLA2G2A P14555 1/20 0.36
PLA2G4A P47712 1/20 0.36
PIM1 P11309 2/20 0.36
GGPS1 O95749 1/20 0.36
CYP1A2 P05177 3/20 0.36
KMT2A Q03164 3/20 0.36
PRKDC P78527 2/20 0.36
KDM4E B2RXH2 2/20 0.36
TP53 P04637 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HSD17B10 Q99714 2/20 0.36
MEN1 O00255 2/20 0.36
ACACA Q13085 1/20 0.36
LMNA P02545 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19397495 0.97 CYP1A1 (0.46) ALOX5CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL19397386 0.96 ALOX5 (0.46) ALOX5CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL22104545 0.96 ALOX5 (0.46) ALOX5CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL19397598 0.94 ALOX5 (0.48) ALOX5ALDH1A1MAPTPLA2G2APLA2G4A
SCHEMBL17899221 0.92 ALOX5 (0.45) ALOX5CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL17899238 0.92 ALOX5 (0.45) ALOX5CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL24687348 0.92 ALOX5 (0.47) ALOX5CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL15501754 0.92 ALOX5 (0.47) ALOX5CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL15501576 0.92 ALOX5 (0.47) ALOX5CYP1A1CYP1B1ALDH1A1MAPT
SCHEMBL19397382 0.92 ALOX5 (0.50) ALOX5ALDH1A1MAPTPLA2G2APLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2020-03-03 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same C1S, AOC2, L1CAM ALOX5 2060/4885CYP1A1 83/4885CYP1B1 307/4885
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME L1CAM, C1S, F10 ALOX5 2055/4885CYP1A1 241/4885CYP1B1 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.